Vaccinia virus entry is followed by core activation and proteasome-mediated release of the immunomodulatory effector VH1 from lateral bodies

Cell Reports

Volumn 4, Issue 3, 2013, Pages 464-476

  Schmidt, FlorianIngo ^a   Bleck, ChristopherKarlErnst ^b   Reh, Lucia ^a   Novy, Karel ^a   Wollscheid, Bernd ^a   Helenius, Ari ^a   Stahlberg, Henning ^b   Mercer, Jason ^a  

^a ETH ZURICH   (Switzerland)

^b UNIVERSITY OF BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

DUAL SPECIFICITY PHOSPHATASE 3; GAMMA INTERFERON; GLUTAREDOXIN; GLUTAREDOXIN G4; PHOSPHOPROTEIN; PHOSPHOPROTEIN F17; PROTEASOME; STAT1 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELLULAR DISTRIBUTION; CHLOROCEBUS; CONTROLLED STUDY; CYTOSOL; DRUG RESPONSE; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IMMUNOMODULATION; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN DEGRADATION; PROTEIN DEPHOSPHORYLATION; PROTEIN LOCALIZATION; VACCINIA VIRUS; VIRUS CORE; VIRUS ENTRY;

POXVIRIDAE; VACCINIA VIRUS;

ANIMALS; CELL LINE; CERCOPITHECUS AETHIOPS; DUAL-SPECIFICITY PHOSPHATASES; HELA CELLS; HUMANS; PROTEASOME ENDOPEPTIDASE COMPLEX; SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR; VACCINIA; VACCINIA VIRUS; VIRAL PROTEINS; VIRUS ACTIVATION;

EID: 84881614606     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2013.06.028     Document Type: Article

References (70)

1. Banham A.H., Smith G.L. Vaccinia virus gene B1R encodes a 34-kDa serine/threonine protein kinase that localizes in cytoplasmic factories and is packaged into virions. Virology 1992, 191:803-812.
2. Bengali Z., Satheshkumar P.S., Moss B. Orthopoxvirus species and strain differences in cell entry. Virology 2012, 433:506-512.
3. Bleck C.K., Merz A., Gutierrez M.G., Walther P., Dubochet J., Zuber B., Griffiths G. Comparison of different methods for thin section EM analysis of Mycobacterium smegmatis. J.Microsc. 2010, 237:23-38.
4. Castaño-Díez D., Kudryashev M., Arheit M., Stahlberg H. Dynamo: a flexible, user-friendly development tool for subtomogram averaging of cryo-EM data in high-performance computing environments. J.Struct. Biol. 2012, 178:139-151.
5. Chang A., Metz D.H. Further investigations on the mode of entry of vaccinia virus into cells. J.Gen. Virol. 1976, 32:275-282.
6. Chang S.J., Chang Y.X., Izmailyan R., Tang Y.L., Chang W. Vaccinia virus A25 and A26 proteins are fusion suppressors for mature virions and determine strain-specific virus entry pathways into HeLa, CHO-K1, and Lcells. J.Virol. 2010, 84:8422-8432.
7. Chung C.S., Chen C.H., Ho M.Y., Huang C.Y., Liao C.L., Chang W. Vaccinia virus proteome: identification of proteins in vaccinia virus intracellular mature virion particles. J.Virol. 2006, 80:2127-2140.
8. Condit R.C., Moussatche N., Traktman P. In a nutshell: structure and assembly of the vaccinia virion. Adv. Virus Res. 2006, 66:31-124.
9. Cyrklaff M., Risco C., Fernández J.J., Jiménez M.V., Estéban M., Baumeister W., Carrascosa J.L. Cryo-electron tomography of vaccinia virus. Proc. Natl. Acad. Sci. USA 2005, 102:2772-2777.
10. Cyrklaff M., Linaroudis A., Boicu M., Chlanda P., Baumeister W., Griffiths G., Krijnse-Locker J. Whole cell cryo-electron tomography reveals distinct disassembly intermediates of vaccinia virus. PLoS ONE 2007, 2:e420.
11. Dales S. The uptake and development of vaccinia virus in strain L cells followed with labeled viral deoxyribonucleic acid. J.Cell Biol. 1963, 18:51-72.
12. Damon I.K. Poxviruses. Fields Virology 2007, 2947. Lippincott-Raven, Philadelphia. D.M. Knipe, P.M. Howley (Eds.).
13. Derrien M., Punjabi A., Khanna M., Grubisha O., Traktman P. Tyrosine phosphorylation of A17 during vaccinia virus infection: involvement of the H1 phosphatase and the F10 kinase. J.Virol. 1999, 73:7287-7296.
14. Easterbrook K.B. Controlled degradation of vaccinia virions invitro: an electron microscopic study. J.Ultrastruct. Res. 1966, 14:484-496.
15. Gong S.C., Lai C.F., Esteban M. Vaccinia virus induces cell fusion at acid pH and this activity is mediated by the N-terminus of the 14-kDa virus envelope protein. Virology 1990, 178:81-91.
16. Griffiths G., Burke B., Lucocq J. Fine structure immunocytochemistry 1993, Springer-Verlag, Berlin.
17. Hollinshead M., Vanderplasschen A., Smith G.L., Vaux D.J. Vaccinia virus intracellular mature virions contain only one lipid membrane. J.Virol. 1999, 73:1503-1517.
18. Huang C., Samsonoff W.A., Grzelecki A. Vaccinia virus recombinants expressing an 11-kilodalton beta-galactosidase fusion protein incorporate active beta-galactosidase in virus particles. J.Virol. 1988, 62:3855-3861.
19. Huang C.Y., Lu T.Y., Bair C.H., Chang Y.S., Jwo J.K., Chang W. A novel cellular protein, VPEF, facilitates vaccinia virus penetration into HeLa cells through fluid phase endocytosis. J.Virol. 2008, 82:7988-7999.
20. Ichihashi Y., Oie M., Tsuruhara T. Location of DNA-binding proteins and disulfide-linked proteins in vaccinia virus structural elements. J.Virol. 1984, 50:929-938.
21. Iyer L.M., Balaji S., Koonin E.V., Aravind L. Evolutionary genomics of nucleo-cytoplasmic large DNA viruses. Virus Res. 2006, 117:156-184.
22. Joklik W.K. The Intracellular Uncoating of Poxvirus DNA. I. The Fate of Radioactively-Labeled Rabbitpox Virus. J.Mol. Biol. 1964, 8:263-276.
23. Joklik W.K. The intracellular uncoating of poxvirus DNA. II. The molecular basis of the uncoating process. J.Mol. Biol. 1964, 8:277-288.
24. Kao S.Y., Bauer W.R. Biosynthesis and phosphorylation of vaccinia virus structural protein VP11. Virology 1987, 159:399-407.
25. Kao S.Y., Ressner E., Kates J., Bauer W.R. Purification and characterization of a superhelix binding protein from vaccinia virus. Virology 1981, 111:500-508.
26. Koksal A.C., Cingolani G. Dimerization of Vaccinia virus VH1 is essential for dephosphorylation of STAT1 at tyrosine 701. J.Biol. Chem. 2011, 286:14373-14382.
27. Laliberte J.P., Weisberg A.S., Moss B. The membrane fusion step of vaccinia virus entry is cooperatively mediated by multiple viral proteins and host cell components. PLoS Pathog. 2011, 7:e1002446.
28. Law M., Carter G.C., Roberts K.L., Hollinshead M., Smith G.L. Ligand-induced and nonfusogenic dissolution of a viral membrane. Proc. Natl. Acad. Sci. USA 2006, 103:5989-5994.
29. Liu K., Lemon B., Traktman P. The dual-specificity phosphatase encoded by vaccinia virus, VH1, is essential for viral transcription invivo and invitro. J.Virol. 1995, 69:7823-7834.
30. Liu G., Zhai Q., Schaffner D.J., Wu A., Yohannes A., Robinson T.M., Maland M., Wells J., Voss T.G., Bailey C., Alibek K. Prevention of lethal respiratory vaccinia infections in mice with interferon-alpha and interferon-gamma. FEMS Immunol. Med. Microbiol. 2004, 40:201-206.
31. Locker J.K., Griffiths G. An unconventional role for cytoplasmic disulfide bonds in vaccinia virus proteins. J.Cell Biol. 1999, 144:267-279.
32. MacCallum F.O., McDonald J.R. Effect of temperatures of up to 45 degrees C on survival of variola virus in human material in relation to laboratory diagnosis. Bull. World Health Organ. 1957, 16:441-443.
33. MacMicking J.D. Interferon-inducible effector mechanisms in cell-autonomous immunity. Nat. Rev. Immunol. 2012, 12:367-382.
34. Mann B.A., Huang J.H., Li P., Chang H.C., Slee R.B., O'Sullivan A., Anita M., Yeh N., Klemsz M.J., Brutkiewicz R.R., et al. Vaccinia virus blocks Stat1-dependent and Stat1-independent gene expression induced by type I and type II interferons. J.Interferon Cytokine Res. 2008, 28:367-380.
35. McDonald K. Osmium ferricyanide fixation improves microfilament preservation and membrane visualization in a variety of animal cell types. J.Ultrastruct. Res. 1984, 86:107-118.
36. Mercer J., Traktman P. Genetic and cell biological characterization of the vaccinia virus A30 and G7 phosphoproteins. J.Virol. 2005, 79:7146-7161.
37. Mercer J., Helenius A. Vaccinia virus uses macropinocytosis and apoptotic mimicry to enter host cells. Science 2008, 320:531-535.
38. Mercer J., Snijder B., Sacher R., Burkard C., Bleck C.K., Stahlberg H., Pelkmans L., Helenius A. RNAi screening reveals proteasome- and Cullin3-dependent stages in vaccinia virus infection. Cell Rep. 2012, 2:1036-1047.
39. Moss B. Poxvirus cell entry: how many proteins does it take?. Viruses 2012, 4:688-707.
40. Munyon W., Paoletti E., Grace J.T. RNA polymerase activity in purified infectious vaccinia virus. Proc. Natl. Acad. Sci. USA 1967, 58:2280-2287.
41. Najarro P., Traktman P., Lewis J.A. Vaccinia virus blocks gamma interferon signal transduction: viral VH1 phosphatase reverses Stat1 activation. J.Virol. 2001, 75:3185-3196.
42. Pedersen K., Snijder E.J., Schleich S., Roos N., Griffiths G., Locker J.K. Characterization of vaccinia virus intracellular cores: implications for viral uncoating and core structure. J.Virol. 2000, 74:3525-3536.
43. Resch W., Hixson K.K., Moore R.J., Lipton M.S., Moss B. Protein composition of the vaccinia virus mature virion. Virology 2007, 358:233-247.
44. Rock K.L., Gramm C., Rothstein L., Clark K., Stein R., Dick L., Hwang D., Goldberg A.L. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell 1994, 78:761-771.
45. Rosel J.L., Earl P.L., Weir J.P., Moss B. Conserved TAAATG sequence at the transcriptional and translational initiation sites of vaccinia virus late genes deduced by structural and functional analysis of the HindIII H genome fragment. J.Virol. 1986, 60:436-449.
46. Sarov I., Joklik W.K. Studies on the nature and location of the capsid polypeptides of vaccinia virions. Virology 1972, 50:579-592.
47. Satheshkumar P.S., Anton L.C., Sanz P., Moss B. Inhibition of the ubiquitin-proteasome system prevents vaccinia virus DNA replication and expression of intermediate and late genes. J.Virol. 2009, 83:2469-2479.
48. Schliwa M., Euteneuer U., Bulinski J.C., Izant J.G. Calcium lability of cytoplasmic microtubules and its modulation by microtubule-associated proteins. Proc. Natl. Acad. Sci. USA 1981, 78:1037-1041.
49. Schmidt F.I., Bleck C.K., Helenius A., Mercer J. Vaccinia extracellular virions enter cells by macropinocytosis and acid-activated membrane rupture. EMBO J. 2011, 30:3647-3661.
50. Schmidt F.I., Bleck C.K., Mercer J. Poxvirus host cell entry. Curr. Opin. Virol. 2012, 2:20-27.
51. Schulz K.R., Danna E.A., Krutzik P.O., Nolan G.P. Single-cell phospho-protein analysis by flow cytometry. Curr. Protoc. Immunol. 2012, Chapter 8. Unit 8.17.
52. Senkevich T.G., Weisberg A.S., Moss B. Vaccinia virus E10R protein is associated with the membranes of intracellular mature virions and has a role in morphogenesis. Virology 2000, 278:244-252.
53. Senkevich T.G., White C.L., Koonin E.V., Moss B. Complete pathway for protein disulfide bond formation encoded by poxviruses. Proc. Natl. Acad. Sci. USA 2002, 99:6667-6672.
54. Senkevich T.G., Ojeda S., Townsley A., Nelson G.E., Moss B. Poxvirus multiprotein entry-fusion complex. Proc. Natl. Acad. Sci. USA 2005, 102:18572-18577.
55. Slot J.W., Geuze H.J. Cryosectioning and immunolabeling. Nat. Protoc. 2007, 2:2480-2491.
56. Smiley J.R. Herpes simplex virus virion host shutoff protein: immune evasion mediated by a viral RNase?. J.Virol. 2004, 78:1063-1068.
57. Sommer A., Traut R.R. Diagonal polyacrylamide-dodecyl sulfate gel electrophoresis for the identification of ribosomal proteins crosslinked with methyl-4-mercaptobutyrimidate. Proc. Natl. Acad. Sci. USA 1974, 71:3946-3950.
58. Stiefel P., Schmidt F.I., Dörig P., Behr P., Zambelli T., Vorholt J.A., Mercer J. Cooperative vaccinia infection demonstrated at the single-cell level using FluidFM. Nano Lett. 2012, 12:4219-4227.
59. Teale A., Campbell S., Van Buuren N., Magee W.C., Watmough K., Couturier B., Shipclark R., Barry M. Orthopoxviruses require a functional ubiquitin-proteasome system for productive replication. J.Virol. 2009, 83:2099-2108.
60. Terajima M., Leporati A.M. Role of Indoleamine 2,3-Dioxygenase in Antiviral Activity of Interferon-gamma Against Vaccinia Virus. Viral Immunol. 2005, 18:722-729.
61. Tokuyasu K.T. A technique for ultracryotomy of cell suspensions and tissues. J.Cell Biol. 1973, 57:551-565.
62. Tokuyasu K.T. Immunochemistry on ultrathin frozen sections. Histochem. J. 1980, 12:381-403.
63. Traktman P., Liu K., DeMasi J., Rollins R., Jesty S., Unger B. Elucidating the essential role of the A14 phosphoprotein in vaccinia virus morphogenesis: construction and characterization of a tetracycline-inducible recombinant. J.Virol. 2000, 74:3682-3695.
64. Trilling M., Le V.T., Zimmermann A., Ludwig H., Pfeffer K., Sutter G., Smith G.L., Hengel H. Gamma interferon-induced interferon regulatory factor 1-dependent antiviral response inhibits vaccinia virus replication in mouse but not human fibroblasts. J.Virol. 2009, 83:3684-3695.
65. White C.L., Weisberg A.S., Moss B. A glutaredoxin, encoded by the G4L gene of vaccinia virus, is essential for virion morphogenesis. J.Virol. 2000, 74:9175-9183.
66. White C.L., Senkevich T.G., Moss B. Vaccinia virus G4L glutaredoxin is an essential intermediate of a cytoplasmic disulfide bond pathway required for virion assembly. J.Virol. 2002, 76:467-472.
67. Wickramasekera N.T., Traktman P. Structure/Function analysis of the vaccinia virus F18 phosphoprotein, an abundant core component required for virion maturation and infectivity. J.Virol. 2010, 84:6846-6860.
68. Wolffe E.J., Vijaya S., Moss B. A myristylated membrane protein encoded by the vaccinia virus L1R open reading frame is the target of potent neutralizing monoclonal antibodies. Virology 1995, 211:53-63.
69. Yang Z., Moss B. Interaction of the vaccinia virus RNA polymerase-associated 94-kilodalton protein with the early transcription factor. J.Virol. 2009, 83:12018-12026.
70. Yang W.P., Kao S.Y., Bauer W.R. Biosynthesis and post-translational cleavage of vaccinia virus structural protein VP8. Virology 1988, 167:585-590.